surmount study tirzepatide SURMOUNT‐1 design. This is a phase 3, multicenter, randomized, Tirzepatide after intensive lifestyle intervention

To read more in detail (and explore the research further):

Because it can impact how we feel every single day

Over 14 weeks, I lost 120 lbs, and for the first time in a very long time, I actually feel like myself again

Sciwind Biosciences has shared late-stage trial data for its injectable GLP-1 therapy, signaling Chinese firms intensifying bid to challenge incumbents like Eli Lilly (NYSE: LLY) and Novo Nordisk (NOV: N) in the global obesity drug market

Wegovy in our 2026 guide

A Big Step Toward Affordable Diabetes & Obesity Care in India Alkems introduction of Semaglutide Injection in a pre-filled syringe format marks an important development for Indian healthcare